Dihydromyricetin Improves Ulcerative Colitis by Suppressing NLRP3 Inflammasome Activation Caused by Dysbiosis of Gut Microbiota
DMY helps regulate intestinal homeostasis in colitis mice by suppressing the NLRP3 inflammasome via the gut microbiota. Our study provides new evidence supporting DMY as a potential therapeutic agent for colitis.
Authors
- Tianxiang Zhu (ORCID: https://orcid.org/0009-0007-2465-7313)
- Lu Cao (ORCID: https://orcid.org/0000-0002-3602-0340)
- Shengchen Ding
- Baifei Hu (ORCID: https://orcid.org/0000-0002-8006-4877)
- Zhigang Zhang (ORCID: https://orcid.org/0000-0001-8965-223X)
- Hongtao Liu (ORCID: https://orcid.org/0000-0003-0149-6389)
- Jun Chen (ORCID: https://orcid.org/0000-0003-2788-4021)
- Yi Dai
- Huabing Yang (ORCID: https://orcid.org/0000-0002-6642-0492)
Institutions
- Hubei University of Chinese Medicine (CN)
- Wuhan City Chinese Medicine Hospital (CN)
- Wuhan Ship Development & Design Institute (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/jir.s545159
- Primary Topic
- Medicinal plant effects and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00